Novacap

Read more
Pierre Luzeau's photo - CEO of Novacap

CEO

Pierre Luzeau

CEO Approval Rating

69/100

Est. Annual Revenue
$668M
Est. Employees
3,000

NOVACAP TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Pierre Luzeau

CEO

- -
3,000
$0
$668M
View Profile
1

Dawid Jakubowicz

President & CEO

82/100
3,705
- -
$811.4M
View Profile
2

Thomas Kalwat

Chairman & CEO

70/100
936
- -
$85.7M
View Profile
3

Ilham Kadri

Chairman & CEO

77/100
23,000
- -
$11.1B
View Profile
4

Thierry Vanlancker

Chairman & CEO

90/100
32,700
- -
$11.5B
View Profile
5

Thierry Le Henaff

Chairman & CEO

73/100
20,600
- -
$10B
View Profile
6

Marian Rybak

CEO

66/100
4,723
- -
$821.7M
View Profile
7

Jim Ratcliffe

Chairman & CEO

80/100
7,700
- -
$13.9B
View Profile
8

Matthias Mirbach

Managing Director

- -
- -
View Profile
9

Miguel Mantas

CEO

80/100
4,000
- -
$2.5B
View Profile
10

Nick Patey

Managing Director

83/100
20
- -
$5.8M
View Profile

Missing a competitor? Contribute!

CIECH is Novacap's top competitor. CIECH was founded in 1945 in Warsaw, Masovia. CIECH competes in the Specialty Chemicals field. CIECH generates $143.4M more revenue than Novacap.

Synthos is perceived as one of Novacap's biggest rivals. Synthos's headquarters is in Oświęcim, Lesser Poland, and was founded in 1945. Synthos is in the Diversified Metals & Mining industry. Synthos generates 12% of Novacap's revenue.

Solvay is one of Novacap's top competitors. Solvay is a Public company that was founded in Brussels, Brussels-Capital Region in 1863. Solvay operates in the Specialty Chemicals industry. Solvay has 20,000 more employees vs. Novacap.

Novacap Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
PCI Synthesis, Inc.

Jun 2018

Source »
undisclosed
PCI Synthesis is a pharmaceutical contract manufacturing firm offering process research, early-stage development and commercial production services.
Chemoxy International Ltd.

Jul 2017

Source »
undisclosed
Chemoxy is a manufacturer and distributor of specialty chemicals and solvents for pharmaceuticals, electronics and construction sectors.

These are all the companies that Novacap has acquired. Novacap has acquired 2 companies and its latest acquisition was PCI Synthesis, Inc. in Jun 2018. PCI Synthesis is a pharmaceutical contract manufacturing firm offering process research, early-stage development and commercial production services.

Novacap Funding History

No recent funding data found related to Novacap

Novacap Investments

No recent investments found related to Novacap

Novacap News

December 1, 20174-traders

joined the mouvement #FrenchFab�!

(4-traders.com) French Fab is the new surname of French industry. It embodies the thousands of SMEs a... See more »
July 19, 2017CosmeticsDesign-Europe

Novacap acquires specialty chemicals player Chemoxy

Novacap, a worldwide player in the pharmaceutical and chemical industries, announced today that it ha... See more »
July 18, 2017FoodNavigator-Asia

Novacap's first sodium bicarbonate plant in Asia opens in Singapore

Novacap has officially opened a sodium bicarbonate plant in Singapore, the first of its kind for the ... See more »
July 3, 2017Real Deals

BGF sells Chemoxy to Eurazeo-backed Novacap

The Business Growth Fund has sold chemicals manufacturer Chemoxy International to Eurazeo-backed trad... See more »
May 30, 2017FoodNavigator-Asia

Novacap prepares to open new sodium bicarbonate plant in Singapore

Novacap is preparing to open a stand-alone sodium bicarbonate plant in Singapore to help the French f... See more »
May 14, 20174-traders

Project of strategic combination between Novacap and PCAS

(4-traders.com) Press release PROJECT OF STRATEGIC COMBINATION BETWEEN NOVACAP AND PCAS THROUGH A SAL... See more »

Novacap Press Releases

August 4, 2015CNW

NOVACAP announces the acquisition of Hallcon Corporation

MONTRÉAL, Aug. 4, 2015 /CNW Telbec/ - NOVACAP, a Canadian leader in private equity, today announced t... See more »

Novacap Videos

Social Media

Novacap Headquarters

21 chemin de la Sauvegarde 21 Ecully Parc

ECULLY Cedex, Île-de-FranceCS 33167

33-426-99-18-00

Driving Directions »

Trending Companies

Novacap Summary

ABOUT

Overview

Novacap is a pharmaceutical and a chemical firm specializes in distribution of aspirin and sodium bicarbonate products. Novacap was founded in 2003. Novacap's headquarters is located in ECULLY Cedex, Île-de-France, FR CS 33167. Novacap's latest acquis...

CEO

Novacap's CEO, Pierre Luzeau, currently has an approval rating of 69%. Novacap's primary competitors are CIECH, Synthos & Solvay.

Website

novacap.eu

Frequently Asked Questions about Novacap

  1. When was Novacap founded?

    Novacap was founded in 2003
  2. Who is Novacap's CEO?

    Novacap's CEO is Pierre Luzeau
  3. How much revenue does Novacap generate?

    Novacap generates $668M in revenue
  4. How much funding does Novacap have?

    Novacap has historically raised $0 in funding
  1. Where is Novacap's headquarters?

    Novacap's headquarters is in ECULLY Cedex Île-de-France, FR
  2. How many employees does Novacap have?

    Novacap has 3,000 employees
  3. What sector does Novacap operate in?

    Novacap is in Life Sciences
  4. Who are Novacap's competitors?

    Novacap's top competitors are CIECH, Synthos, Solvay